Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.04 USD | -6.76% | -2.91% | 0.00% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LENZ THERAPEUTICS, INC. | Bio Therapeutic Drugs | -6.76% | -2.91% | - | - | - | 412M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- LENZ Stock
- Charts LENZ Therapeutics, Inc.
- Comparison Chart